SE444937B - N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat - Google Patents

N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat

Info

Publication number
SE444937B
SE444937B SE7910204A SE7910204A SE444937B SE 444937 B SE444937 B SE 444937B SE 7910204 A SE7910204 A SE 7910204A SE 7910204 A SE7910204 A SE 7910204A SE 444937 B SE444937 B SE 444937B
Authority
SE
Sweden
Prior art keywords
imidazole
ethyl
alkyl
group
compound
Prior art date
Application number
SE7910204A
Other languages
English (en)
Swedish (sv)
Other versions
SE7910204L (sv
Inventor
P E Cross
R P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE444937(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of SE7910204L publication Critical patent/SE7910204L/xx
Publication of SE444937B publication Critical patent/SE444937B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7910204A 1978-12-13 1979-12-11 N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat SE444937B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13

Publications (2)

Publication Number Publication Date
SE7910204L SE7910204L (sv) 1980-06-14
SE444937B true SE444937B (sv) 1986-05-20

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7910204A SE444937B (sv) 1978-12-13 1979-12-11 N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat

Country Status (34)

Country Link
US (2) US4602016A (ja)
JP (1) JPS585197B2 (ja)
KR (1) KR830001243B1 (ja)
AR (1) AR227637A1 (ja)
AT (1) AT373879B (ja)
AU (1) AU517892B2 (ja)
BE (1) BE880584A (ja)
CA (1) CA1108137A (ja)
CH (1) CH644597A5 (ja)
CS (1) CS216517B2 (ja)
DD (1) DD147943A5 (ja)
DE (1) DE2950019A1 (ja)
DK (1) DK471479A (ja)
EG (1) EG14227A (ja)
ES (1) ES486782A0 (ja)
FI (1) FI70888C (ja)
FR (1) FR2444031A1 (ja)
GB (1) GB2038821B (ja)
GR (1) GR73003B (ja)
HU (1) HU183016B (ja)
IE (1) IE49318B1 (ja)
IL (1) IL58917A (ja)
IT (1) IT1194900B (ja)
LU (1) LU81985A1 (ja)
NL (1) NL177749C (ja)
NO (1) NO153135C (ja)
NZ (1) NZ192360A (ja)
PH (1) PH15056A (ja)
PL (1) PL134005B1 (ja)
PT (1) PT70571A (ja)
SE (1) SE444937B (ja)
SU (1) SU878195A3 (ja)
YU (1) YU301879A (ja)
ZA (1) ZA796708B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES8601148A1 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
US4894385A (en) * 1985-01-16 1990-01-16 Sankyo Company Limited Imidazole derivatives as inhibitors of TXA2 synthesis
SU1739848A3 (ru) 1986-01-28 1992-06-07 Санкио Компани Лимитед (Фирма) Способ получени производных тианафтена или их фармацевтически приемлемых солей
ATE90076T1 (de) 1986-03-27 1993-06-15 Merck Frosst Canada Inc Tetrahydrocarbazole ester.
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
ATE57925T1 (de) * 1987-04-03 1990-11-15 Cl Pharma Neue 2-thienyloxyessigsaeurederivate, ein verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
EP0757677B1 (en) * 1994-04-26 2003-06-18 Syntex (U.S.A.) LLC Benzocyclohexylimidazolethione derivatives
WO1999045905A2 (en) * 1998-03-13 1999-09-16 Pozen Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
CN1665538A (zh) * 2002-07-09 2005-09-07 B·M·R·A·有限公司 血栓烷a2受体拮抗剂和cox－2抑制剂的药物组合
JP2007508242A (ja) * 2003-08-07 2007-04-05 ビー．エム．アール．エイ． コーポレイション ベスローテン フェンノートシャップ トロンボキサンａ２受容体アンタゴニストとシクロオキシゲネーゼ−１の阻害剤との組み合わせを伴う組成物および方法
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
EP2234608A2 (en) 2007-12-11 2010-10-06 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
CN104718188B (zh) * 2012-05-22 2018-08-21 基因泰克公司 N-取代的苯甲酰胺类及其在治疗疼痛中的用途
CA2891056A1 (en) 2012-10-26 2014-05-01 Merck Sharp & Dohme Corp. N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
EP4538258A4 (en) * 2022-06-13 2025-07-30 Hefei Inst Of Pharmaceutical Industry Co Ltd IMIDAZOLIDINYL VANILLIC ACID ETHER DERIVATIVE AND ITS USE
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
NL7908899A (nl) 1980-06-17
CH644597A5 (de) 1984-08-15
LU81985A1 (fr) 1980-04-22
IL58917A0 (en) 1980-03-31
IE49318B1 (en) 1985-09-18
IL58917A (en) 1984-03-30
HU183016B (en) 1984-04-28
FI70888C (fi) 1986-10-27
PL220351A1 (ja) 1980-12-01
ES8101556A1 (es) 1980-12-16
FR2444031A1 (fr) 1980-07-11
NL177749B (nl) 1985-06-17
KR830001243B1 (ko) 1983-06-27
IT1194900B (it) 1988-09-28
CA1108137A (en) 1981-09-01
FI793868A7 (fi) 1980-06-14
IE792403L (en) 1980-06-13
ES486782A0 (es) 1980-12-16
ATA783379A (de) 1983-07-15
US4636500A (en) 1987-01-13
NL177749C (nl) 1985-11-18
IT7941669A0 (it) 1979-12-11
NO153135B (no) 1985-10-14
YU301879A (en) 1983-01-21
SU878195A3 (ru) 1981-10-30
AU517892B2 (en) 1981-09-03
CS216517B2 (en) 1982-11-26
EG14227A (en) 1983-12-31
BE880584A (fr) 1980-06-12
FR2444031B1 (ja) 1983-06-10
GB2038821B (en) 1982-12-08
ZA796708B (en) 1981-08-26
KR830001242A (ko) 1983-04-29
NO794069L (no) 1980-06-16
PL134005B1 (en) 1985-07-31
DE2950019A1 (de) 1980-07-10
US4602016A (en) 1986-07-22
SE7910204L (sv) 1980-06-14
JPS5585572A (en) 1980-06-27
JPS585197B2 (ja) 1983-01-29
NO153135C (no) 1986-01-22
NZ192360A (en) 1982-02-23
FI70888B (fi) 1986-07-18
AT373879B (de) 1984-02-27
DD147943A5 (de) 1981-04-29
PH15056A (en) 1982-06-03
DK471479A (da) 1980-06-14
PT70571A (en) 1980-01-01
GB2038821A (en) 1980-07-30
AR227637A1 (es) 1982-11-30
GR73003B (ja) 1984-01-24
AU5372579A (en) 1980-06-19

Similar Documents

Publication Publication Date Title
SE444937B (sv) N-(fenoxialkyl)-imidazolderivat, sett att framstella dessa samt farmaceutisk beredning innehallande ett sadant derivat
US4273782A (en) Inhibition of thromboxane synthetase by 3-(1-Imidazolylalkyl) indoles
US5827869A (en) Substituted biphenyl isoxazole sulfonamides
US4448781A (en) N-Benzyl-imidazoles as selective inhibitors of the thromboxane synthetase enzyme
EP0035863B1 (en) Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4339583A (en) (Imidazolylmethyl)pyridine compounds as thromboxane synthetase inhibitors
JP2006500352A (ja) マトリックスメタロプロテイナーゼ阻害剤としてのヘテロビアリール誘導体
GB2041363A (en) N-Benzyl-imidazoles
EP0054417A1 (en) Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
US4451472A (en) Inhibition of thromboxane synthetase with 3-(heteroalkyl)-indolyl-acrylic acid derivatives
GB2065121A (en) Isoquinoline Derivatives
US4230714A (en) Imidazole therapeutic agents
US4347371A (en) Disulfide compounds
GB2045244A (en) 3-1-(Imidazolylalkyl) indoles
HUT52038A (en) Process for producing alpha-cyano-beta-oxo-propion-amides
GB2068950A (en) Pyridine Derivatives
GB2101115A (en) Thromboxane synthetase inhibitors
GB2102795A (en) Indole derivatives
JPS6323848A (ja) Ω−（置換フエニルオキシ）−アルカン酸のアリ−ル−およびアラルキルアミド
RU2322440C1 (ru) Замещенные омега-азолилалкананилиды, способ их получения и применение в качестве антиагрегантов